John Seymour, MBBS, FRACP, PhD, explains the mechanism of action of BCL-2 inhibitors like venetoclax. John Seymour, MBBS, FRACP, PhD, director of hematology at the Peter MacCallum Cancer Center and ...

This new agent, like the other DPP-4 inhibitors, has a mechanism of action that affects both pancreatic ß-cell survival as well as ß-cell secretory function. These medications do not incite ...

they shed light on the selectivity of BRAF inhibitors by delineating the main structural changes occurring during dimerization and inhibitor action. Notably, they identify the two pivotal elements in ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Institute of Flexible Electronics (IFE, Future Technologies), Xiang’an Campus, Xiamen University, Xiang’an South Road, Xiamen 361102, Fujian, China State Key Laboratory of Physical Chemistry of Solid ...

selective FAK inhibitor, in adult patients with recurrent KRAS mutant LGSOC and designated June 30, 2025, as the Prescription ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

Botox has long been touted as the “secret of youth.” However, everyone knows that it changes facial features (and not always ...